I’m excited to announce that top scientific suppliers BioLegend, Charles River Laboratories, Corning Incorporated, DDC Medical, EMD Millipore, Harlan Laboratories, LI-COR Biosciences, Mirus Bio, Novus Biologicals, and Sigma-Aldrich will provide more than $500,000 worth of research reagents and models to support one of our validation projects, the Reproducibility Project: Cancer Biology. The donation of reagents and models will increase the number of replication experiments that can be conducted for the Reproducibility Project: Cancer Biology, a collaboration between Science Exchange and the Center for Open Science, supported by a $1.3 million grant from the Laura and John Arnold Foundation.
These companies chose to donate to the project, because they are committed to improving the quality of research and we are thrilled to have their support!
The Reproducibility Project: Cancer Biology is independently replicating 50 recent, high-impact cancer biology studies using the Science Exchange network of expert labs. The aim of the project is to use independent replication studies to identify best practices that maximize reproducibility and facilitate an accurate accumulation of knowledge, enabling potentially impactful novel findings to be built upon by the scientific community.
Studies from Amgen and Bayer report that the majority of published results cannot be independently reproduced, but there has been no open systematic review of replication in cancer biology. The Reproducibility Project: Cancer Biology will generate an open replication dataset made available on the Open Science Framework that can be used to examine the rate of reproducibility in this field and to study factors associated with the reproducibility of experimental results.
We continue to be amazed by the wide-ranging support for this project from the scientific community – thank you so much!
Of course, the more scientific supplies that are donated the more we can get done, so if you are involved with a company that is interested in donating please email me here.
[about_box image=”http://thebenchapp.s3.amazonaws.com/wp-content/uploads/2012/03/Elizabeth-80.png”]Elizabeth Iorns is the CEO of Science Exchange and Director of the Reproducibility Initiative. Elizabeth conceived the idea for Science Exchange while an Assistant Professor at the University of Miami and as CEO she drives the company’s vision, strategy and growth. She is passionate about creating a new way to foster scientific collaboration that will break down existing silos, democratize access to scientific expertise and accelerate the speed of scientific discovery. Elizabeth has a Ph.D. in Cancer Biology from the Institute of Cancer Research in London, and conducted postdoctoral research in Cancer Biology from the University of Miami’s Miller School of Medicine where her research focused on identifying mechanisms of breast cancer development and progression.[/about_box]